The company also noted it named ex-CEO and co-founder Nandan Nilekani as a non-executive, non-independent director and chairman of the board of directors. He will replace outgoing chairman, R. Seshasayee, who stepped down from the board Aug. 24.
Jeffrey Lehman and John Etchemendy, PhD, also resigned from the board, effective immediately.
“It has been a great honor and pleasure to serve the shareholders of Infosys for the past three years, and to have a front row seat during the transformative strategies that Vishal Sikka brought as the CEO,” Dr. Etchemendy said, echoing the statements of Dr. Lehman. “With Vishal’s departure, the board and his successor will embark on a new phase in Infosys’ future, and I think that giving up my board seat to a new independent director is the right decision.”
Ravi Venkatesan also stepped down from his role as co-chairman, although he will continue on the Infosys board.
More articles on health IT:
Pew urges ONC to prioritize patient matching, data standardization
Chinese national arrested in US for alleged connection to Sakula malware distribution
Philips to bring 800 jobs to Nashville
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
